z-logo
open-access-imgOpen Access
Viral Triggers and Inflammatory Mechanisms in Pediatric Epilepsy
Author(s) -
Luca Bartolini,
Jane E. Libbey,
Teresa Ravizza,
Robert S. Fujinami,
Steven Jacobson,
William D. Gaillard
Publication year - 2018
Publication title -
molecular neurobiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.569
H-Index - 111
eISSN - 1559-1182
pISSN - 0893-7648
DOI - 10.1007/s12035-018-1215-5
Subject(s) - epileptogenesis , epilepsy , inflammation , mechanism (biology) , neuroscience , picornavirus , medicine , human herpesvirus 6 , neurology , immunology , neuroinflammation , immune system , virus , biology , viral disease , herpesviridae , rna , philosophy , biochemistry , epistemology , gene
Experimental and clinical findings suggest a crucial role for inflammation in the onset of pediatric seizures; this mechanism is not targeted by conventional antiepileptic drugs and may contribute to refractory epilepsy. Several triggers, including infection with neurotropic viruses such as human herpesvirus 6 (HHV-6), other herpesviruses, and picornaviruses, appear to induce activation of the innate and adaptive immune systems, which results in several neuroinflammatory responses, leading to enhanced neuronal excitability, and ultimately contributing to epileptogenesis. This review discusses the proposed mechanisms by which infection with herpesviruses, and particularly with HHV-6, and ensuing inflammation may lead to seizure generation, and later development of epilepsy. We also examine the evidence that links herpesvirus and picornavirus infections with acute seizures and chronic forms of epilepsy. Understanding the mechanisms by which specific viruses may trigger a cascade of alterations in the CNS ultimately leading to epilepsy appears critical for the development of therapeutic agents that may target the virus or inflammatory mechanisms early and prevent progression of epileptogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here